Catalog No.: PC-72218Not For Human Use, Lab Use Only.
CPL304110 (CPL-304110) is a selective and potent pan-FGFR inhibitor with IC50 of 0.75 nM, 0.50 nM, 3.05 nM against FGFR1, 2, 3, shows weaken acitvity against FGFR4 with IC50 of 87.9 nM.
CPL304110 (CPL-304110) is a selective and potent pan-FGFR inhibitor with IC50 of 0.75 nM, 0.50 nM, 3.05 nM against FGFR1, 2, 3, shows weaken acitvity against FGFR4 with IC50 of 87.9 nM.
CPL304110 shows potent anti-tumor activity in vivo, CPL304110 is currently under evaluation in phase I clinical trial for the treatment of bladder, gastric and squamous cell lung cancers.
